Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal Jurnal Ilmu Kesehatan Masyarakat (The Public Health Science Journal) Jurnal Ilmu Kesehatan Masyarakat (The Public Health Science Journal) Jurnal Teknologi Bank Darah
Kusumo, M. Kartono Wijoyo
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
ANALISA PRODUK TIDAK LOLOS RILIS DI UDD PMI KOTA DEPOK BULAN APRIL - JUNI TAHUN 2025 Kartono Wijoyo Kusumo; Widya Astriyani
Jurnal Teknologi Bank Darah JTBD Vol.4 No.1 (Juni 2025)
Publisher : Akademi Bakti Kemanusiaan Palang Merah Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.65228/jtbd.v4i1.21

Abstract

Transfusi Packed Red Cell (PRC) sangat dibutuhkan oleh pasien yang mengalami anemia. Penilaian kualitas komponen darah yang merupakan aspek penting dalam memastikan keamanan dan efektivitas transfusi darah. Berbagai komponen darah, seperti whole blood (darah utuh), packed red cell (sel darah merah pekat), thrombocytesconcentrates (konsentrat trombosit), dan fresh frozen plasma (plasma segar beku), harus memenuhi standar minimalpengendalian kualitas untuk dapat digunakan dalam prosedur medis. Pada penelitian ini dilakukan pengambilan dataterhitung dari bulan April-Juni 2025 ydi UDD PMI Kota Depok. Diperoleh hasil yaitu 9.804 kantong darah PRC yang rilis pada bulan April – Juni. Berdasarkan jumlah tersebut terdapat 28 kantong darah yang tidak lolos produk rilis. Data menunjukkan bahwa total produksi kantong darah dari April-Juni adalah: PRC lolos : 9.804 kantong(99,71%), Lipemik : 24 kantong (0,24%), Clot (pembekuan) : 2 kantong (0,02%), Ikterik : 2 kantong (0,02%). Secara keseluruhan, tingkat kegagalan produk darah PRC sebesar 0,28% (28 kantong dari 9.804), walau terbilangkecil, namun tetap menjadi indikator penting dalam evaluasi mutu pelayanan di UDD PMI Kota Depok. Temuan ini menekankan bahwa proses pengendalian mutu harus dilakukan secara menyeluruh, tidak hanya di tahappascaproduksi, tetapi juga sejak awal seleksi donor, prosedur pengambilan, penyimpanan, hingga pemeriksaan produk.
Hubungan Transfusi Darah Berulang dan Kepatuhan Konsumsi Obat Kelasi Besi dengan Kadar Ferritin pada Pasien Thalasemia di Kota Depok Kusumo, M. Kartono Wijoyo; Novita, Astrid; Hendarwan, Harimat
Jurnal Ilmu Kesehatan Masyarakat Vol 13 No 04 (2024): Jurnal Ilmu Kesehatan Masyarakat
Publisher : UIMA Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33221/jikm.v13i04.2777

Abstract

Repeated transfusions cause iron overload in β thalassemia patients. Therefore, iron chelation therapy is needed to reduce the amount of ferritin and ions in the blood. Compliance with iron chelation therapy is one of the factors that affect the patient's serum ferritin level. This study aims to determine the relationship between repeated blood transfusions and consumption of iron chelating drugs with serum ferritin levels of β thalassemia patients at Depok City Hospital in 2021. This research is a retrospective cohort study. The initial population was 112 people, sampling was carried out using the non-probability method and obtained 69 people who met the inclusion and exclusion criteria. This research was conducted from January 2021 to December 2021 in three medical record installations at Depok City Hospital. Respondents who rarely did repeated blood transfusions were 42 (60.9%), respondents who adhered to taking iron chelation drugs were 45 (65.2%), and respondents who had high ferritin levels were 43 (62.3%). There is a relationship between repeated blood transfusions and ferritin levels in thalassemia patients in Depok City in 2021. There is a relationship between adherence to taking iron chelating drugs and ferritin levels in thalassemia patients in Depok City in 2021. It is recommended that clinicians continue to provide a deeper understanding to parents or the patient's family to continue to carry out regular chelation therapy and check serum ferritin levels regularly.
Hubungan Transfusi Darah Berulang dan Kepatuhan Konsumsi Obat Kelasi Besi dengan Kadar Ferritin pada Pasien Thalasemia di Kota Depok Kusumo, M. Kartono Wijoyo; Novita, Astrid; Hendarwan, Harimat
Jurnal Ilmu Kesehatan Masyarakat Vol. 13 No. 04 (2024): Jurnal Ilmu Kesehatan Masyarakat
Publisher : UIMA Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33221/jikm.v13i04.2777

Abstract

Repeated transfusions cause iron overload in β thalassemia patients. Therefore, iron chelation therapy is needed to reduce the amount of ferritin and ions in the blood. Compliance with iron chelation therapy is one of the factors that affect the patient's serum ferritin level. This study aims to determine the relationship between repeated blood transfusions and consumption of iron chelating drugs with serum ferritin levels of β thalassemia patients at Depok City Hospital in 2021. This research is a retrospective cohort study. The initial population was 112 people, sampling was carried out using the non-probability method and obtained 69 people who met the inclusion and exclusion criteria. This research was conducted from January 2021 to December 2021 in three medical record installations at Depok City Hospital. Respondents who rarely did repeated blood transfusions were 42 (60.9%), respondents who adhered to taking iron chelation drugs were 45 (65.2%), and respondents who had high ferritin levels were 43 (62.3%). There is a relationship between repeated blood transfusions and ferritin levels in thalassemia patients in Depok City in 2021. There is a relationship between adherence to taking iron chelating drugs and ferritin levels in thalassemia patients in Depok City in 2021. It is recommended that clinicians continue to provide a deeper understanding to parents or the patient's family to continue to carry out regular chelation therapy and check serum ferritin levels regularly.
Co-Authors Astrid Novita, Astrid Harimat Hendarwan Widya Astriyani